Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecules (Basel, Switzerland)|December 17, 2016
The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-BromopyruvatePaweł Lis, Mariusz Dyląg, Katarzyna Niedźwiecka, et al.
Journal of Bioenergetics and Biomembranes|February 24, 2012
Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiaePaweł Lis, Marek Zarzycki, Young H Ko, et al.
Oncotarget|February 11, 2016
Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvatePaweł Lis, Paweł Jurkiewicz, Magdalena Cal-Bąkowska, et al.
The Journal of Biological Chemistry|March 15, 2006
Mitochondrial ATP synthase. Crystal structure of the catalytic F1 unit in a vanadate-induced transition-like state and implications for mechanismChen Chen, Ajay K Saxena, William N Simcoke, et al.
Drug Design, Development and Therapy|March 13, 2020
Pleiotropic Anticancer Properties of Scorpion Venom Peptides: <i>Rhopalurus princeps</i> Venom as an Anticancer AgentArthur G Mikaelian, Eric Traboulay, Xiaofei Michael Zhang, et al.
The Biochemical Journal|February 3, 2015
The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pHJoão Azevedo-Silva, Odília Queirós, Ana Ribeiro, et al.
Anti-Cancer Drugs|February 22, 2014
Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapyGrażyna Majkowska-Skrobek, Daria Augustyniak, Paweł Lis, et al.
Oncotarget|September 2, 2016
Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myelomaKatarzyna Niedźwiecka, Mariusz Dyląg, Daria Augustyniak, et al.
Biochemical and Biophysical Research Communications|October 7, 2004
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATPYoung H Ko, Barbara L Smith, Yuchuan Wang, et al.
Journal of Bioenergetics and Biomembranes|February 22, 2012
Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvateOdília Queirós, Ana Preto, António Pacheco, et al.
Pageof 5